Doximity: Valuation Is Too Expensive For My Liking

Doximity (DOCS) is rated Hold amid high valuation, growth slowdown, and new AI-driven opportunities. Read here for more ...

Taking 4p supplement could slash your risk of the most common cancer by ‘up to 50%’ – in as little as a month

TAKING a cheap supplement could slash your risk of skin cancer by up to 50 per cent – and the effects can kick in in as little as a month, researchers say. Non-melanoma skin cancer – ...